More info…
A US-based drug company targeting castration-resistant prostate cancer might seem an unlikely investment for Queensland’s flagship biotechnology fund. (source: The Australian) - RSS news feeds and Widgets on Feedzilla.com
More info…
A US-based drug company targeting castration-resistant prostate cancer might seem an unlikely investment for Queensland’s flagship biotechnology fund. (source: The Australian) - RSS news feeds and Widgets on Feedzilla.com